|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.370 USD | +4.41% |
|
-.--% | +31.67% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart calendar Protalix BioTherapeutics, Inc.
Upcoming events on Protalix BioTherapeutics, Inc.
No events available
Past events on Protalix BioTherapeutics, Inc.
| 25/06/2026 | Annual General Meeting | 16:00 |
| 13/05/2026 | Earnings presentation | 16:00 |
| 13/05/2026 | Earnings release - Q1 2026 | |
| 18/03/2026 | Earnings presentation | 16:00 |
| 18/03/2026 | Earnings release - Annual 2025 | |
| 13/11/2025 | Earnings release - Q3 2025 | |
| 13/11/2025 | Earnings presentation | 17:00 |
| 14/08/2025 | Earnings presentation | 16:30 |
| 14/08/2025 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 65,5 64,0 2.41% | 53,4 53,9 -0.98% | 52,7 58,0 -9.03% | 78,3 | 67,6 | 67,5 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 10,5 11,5 -9.12% | 3,92 1,44 171.26% | -5,50 -0,83 -563.85% | 17,5 | 2,97 | 0,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8,57 9,56 -10.41% | 4,15 1,62 156.18% | -5,61 -0,48 -1061.08% | 18,4 | 4,41 | 0,82 |
|
Net income Million USD | Released Forecast Spread | 8,31 8,12 2.31% | 2,93 1,22 140.03% | -6,60 -0,75 -775.28% | 15,7 | 4,07 | 0,73 |
|
EPS USD | Released Forecast Spread | 0,09 0,11 -14.29% | 0,04 0,02 166.67% | -0,08 -0,01 -1500% | 0,20 | 0,05 | 0,01 |
| Announcement Date | 14/03/24 | 17/03/25 | 18/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,8 16,3 9.72% | 18,2 18,7 -2.81% | 10,1 21,6 -53.18% | 15,7 13,5 16.11% | 17,9 17,9 -0.08% | 9,12 14,4 -36.47% | 33,8 11,5 194.3% | 12,9 | 14,9 | 16,8 | 16,1 | 17,7 | 19,7 | 22,6 |
|
EBIT Million USD | Released Forecast Spread | 3,99 4,39 -9.05% | 7,21 4,74 52.22% | 1,17 2,20 -46.65% | 2,13 4,25 -49.87% | -4,66 0,01 -34603.7% | 21,1 -1,42 1587.06% | -1,32 | -1,04 | -1,26 | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,84 4,29 -10.38% | 7,32 4,90 49.26% | 0,66 2,53 -73.91% | 2,24 4,60 -51.28% | -4,78 0,35 -1468.48% | 21,1 -1,14 1951.23% | -1,02 | -0,75 | -0,97 | |||||
|
Net income Million USD | Released Forecast Spread | 3,24 4,29 -24.53% | 6,49 4,90 32.49% | 0,16 2,38 -93.1% | 2,36 4,44 -47% | -5,50 0,21 -2702.36% | 18,3 -1,01 1906.41% | -0,96 | -0,71 | -0,92 | |||||
|
EPS USD | Released Forecast Spread | 0,03 0,06 -50% | 0,09 0,07 28.57% | -0,05 0,08 -162.5% | 0,00 0,03 - | 0,03 0,06 -45.45% | -0,07 0,01 -1500% | 0,22 -0,01 2300% | -0,01 | -0,01 | -0,01 | 0,01 | 0,01 | 0,03 | 0,07 |
| Announcement Date | 14/11/24 | 17/03/25 | 09/05/25 | 14/08/25 | 13/11/25 | 18/03/26 | 13/05/26 | - | - | - | - | - | - | - |
| 03/08/2026 |  | Information meeting | 16:00 |
| 03/08/2026 | | Earnings release - Q1 2027 | P |
| 03/08/2026 | | Earnings presentation | 12:00 |
| 03/08/2026 | | Earnings release - Q1 2027 | 10:30 |
| 03/08/2026 | | Earnings presentation | 11:00 |
| 03/08/2026 | | Earnings presentation | 16:30 |
| 03/08/2026 | | Earnings release - Q2 2026 | |
| 03/08/2026 | | Présentation aux Actionnaires / Analystes | |
| 03/08/2026 | | Board of Directors Meeting | |
| 03/08/2026 | | Earnings release - Q1 2027 |
Past sector events for Protalix BioTherapeutics, Inc.
| 01/08/2026 | | Earnings release - Q1 2027 | |
| 01/08/2026 | | Board of Directors Meeting | |
| 01/08/2026 | | Earnings presentation | 12:30 |
| 01/08/2026 | | Earnings release - Q2 2026 | |
| 01/08/2026 | | Earnings release - Q2 2026 | |
| 01/08/2026 | | Board of Directors Meeting | |
| 31/07/2026 | | Earnings presentation | 17:00 |
| 31/07/2026 | | Earnings release - Q2 2026 | |
| 31/07/2026 | | Earnings release - Q1 2027 | |
| 31/07/2026 | | Earnings presentation | 12:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- Calendar Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
